Literature DB >> 24338043

Comment on: "EU's new pharmacovigilance legislation: considerations for biosimilars".

John Joseph Borg1, Anthony Serracino-Inglott, Lilian M Azzopardi, Christian K Schneider.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24338043     DOI： 10.1007/s40264-013-0128-5

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  1 in total

1.  Biosimilars-why terminology matters.

Authors:  Martina Weise; Marie-Christine Bielsky; Karen De Smet; Falk Ehmann; Niklas Ekman; Gopalan Narayanan; Hans-Karl Heim; Esa Heinonen; Kowid Ho; Robin Thorpe; Camille Vleminckx; Meenu Wadhwa; Christian K Schneider
Journal:  Nat Biotechnol       Date:  2011-08-05       Impact factor: 54.908
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.